New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 1, 2014
05:27 EDTNVONovo Nordisk reports Q1 EPS down 10% to DKK 2.43
Reports Q1 revenue up 7% in local currencies driven by Levemir and Victoza. Revenue increased by 7% in local currencies and by 2% in Danish kroner to DKK 20.3B. Operating profit increased by 15% in local currencies and by 6% in Danish kroner to DKK 8B.
News For NVO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
06:38 EDTNVONovo Nordisk rejects claims made by Baxter, Reuters says
Novo Nordisk (NVO) rejects claims made by Baxter (BAX) that the company used substances made by Baxter in its Novoeight haemophilia treatment, following Monday's ITC investigation announcement, reports Reuters, citing an email from Novo Nordisk. Reference Link
May 20, 2015
10:26 EDTNVOJanssen acquires licence from Novo Nordisk for autoimmune disease development
Novo Nordisk (NVO) announced it has signed an agreement with Janssen Biotech (JNJ) under which Janssen will acquire an exclusive global license to further develop and commercialize a clinical program focused on therapy within autoimmune diseases. The program targets modulation of certain immune cells via a cell surface receptor, specifically the NKG2D receptor. Terms of the agreement have not been disclosed.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use